Giant Cell Myocarditis Following COVID-19 Successfully Treated by
Immunosuppressive Therapy
- Afsaneh Amiri,
- Golnaz Houshmand,
- Sepideh Taghavi,
- Monireh Kamali,
- Nasim Naderi
Golnaz Houshmand
Rajaie cardiovascular, medical and research center,Iran University of medical sciences
Author ProfileSepideh Taghavi
Rajaie cardiovascular medical and research center,Iran University of medical sciences
Author ProfileNasim Naderi
Rajaie Cardiovascular Medical and Research Center,Iran university of medical sciences
Author ProfileAbstract
In this case report, we present a 46-year-old lady who has developed a
rapidly progressive heart failure after an episode of COVID-19. The
pathologic examination of her endomyocardial biopsy specimens was
compatible with GCM and she was successfully treated with a combined
immunosuppressive therapy regimen.24 Nov 2021Submitted to Clinical Case Reports 13 Dec 2021Submission Checks Completed
13 Dec 2021Assigned to Editor
22 Dec 2021Reviewer(s) Assigned
22 Dec 2021Review(s) Completed, Editorial Evaluation Pending
20 Jan 2022Editorial Decision: Revise Minor
22 Jan 20221st Revision Received
24 Jan 2022Submission Checks Completed
24 Jan 2022Assigned to Editor
24 Jan 2022Review(s) Completed, Editorial Evaluation Pending
13 Feb 2022Reviewer(s) Assigned
07 Mar 2022Editorial Decision: Accept
